Corvus Pharmaceuticals, Inc. (CRVS) vs Monte Rosa Therapeutics, Inc. (GLUE)
Corvus Pharmaceuticals, Inc. and Monte Rosa Therapeutics, Inc. are both Biotechnology companies. Corvus Pharmaceuticals, Inc. and Monte Rosa Therapeutics, Inc. are of similar size ($999.9M and $992.6M). Corvus Pharmaceuticals, Inc. has the higher net margin (0.00% vs −560.9%) and the lower return on invested capital (−352.5% vs 0.00%). Across the 13 metrics below, Corvus Pharmaceuticals, Inc. leads on 9 and Monte Rosa Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | CRVS | GLUE | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (633.04%) | 0.00% |
| Net margin | 0.00% | (560.85%) | 0.00% |
| Free cash flow margin | 0.00% | (111.66%) | 0.00% |
| Return on equity | (18.98%) | (42.66%) | (57.72%) |
| Return on assets | (17.64%) | (30.67%) | (49.22%) |
| Return on invested capital | (352.49%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack